Holm-Jorgensen Rasmus 4
4 · Acrivon Therapeutics, Inc. · Filed Aug 16, 2024
Insider Transaction Report
Form 4
Holm-Jorgensen Rasmus
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-08-14$7.02/sh−368$2,583→ 26,890 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.